EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access · CC BY-NC 4.0

Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis

Richard B Warren, Kerry Donnelly, Sandeep Kiri, Vanessa Taieb, Mahmoud Slim, Kyle Fahrbach, Binod Neupane, Marissa Betts, April Armstrong

Dermatology and Therapy · 2024-11 · 14 (11) · 3133-3147

DOI: 10.1007/s13555-024-01302-0 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Dermatology and Therapy, online erschienen am 01.11.2024. Verfasst von Richard B Warren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: UCB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AdalimumabBimekizumabGuselkumabLong-term efficacyLong-term safetyNetwork meta-analysisPsoriasisRisankizumabSecukinumabUstekinumab

Autor:innen und Institutionen

  • Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • UCB Pharma, Slough, UK.
  • UCB Pharma, Colombes, France.
  • Evidera Inc, St-Laurent, Quebec, Canada.
  • Institute of Neurosciences "Federico Olóriz", University of Granada, Granada, Spain.

Förderung

  • UCB

Zitieren

APA

Warren, R. B., Donnelly, K., Kiri, S., Taieb, V., Slim, M., Fahrbach, K., Neupane, B., Betts, M., & Armstrong, A. (2024). Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis. Dermatology and Therapy, 14(11), 3133-3147. https://doi.org/10.1007/s13555-024-01302-0

Vancouver

Warren RB, Donnelly K, Kiri S, Taieb V, Slim M, Fahrbach K, et al. Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis. Dermatology and Therapy. 2024;14(11):3133-3147. doi:10.1007/s13555-024-01302-0

BibTeX
@article{Warren2024,
  author = {Warren, Richard B and Donnelly, Kerry and Kiri, Sandeep and Taieb, Vanessa and Slim, Mahmoud and Fahrbach, Kyle and Neupane, Binod and Betts, Marissa and Armstrong, April},
  title = {Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis},
  journal = {Dermatology and Therapy},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {3133--3147},
  doi = {10.1007/s13555-024-01302-0}
}
Kostenlos starten →